z-logo
open-access-imgOpen Access
The first Russian experience with the endothelin 1 receptor inhibitor traclir used in patients with pulmonary hypertension associated with systemic connective tissue diseases
Author(s) -
А. В. Волков,
T V Martynyuk,
Н. Н. Юдкина,
Н. М. Данилов,
Т. М. Решетняк,
И Е Чазова,
Евгений Львович Насонов
Publication year - 2011
Publication title -
naučno-praktičeskaâ revmatologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.137
H-Index - 9
eISSN - 1995-4492
pISSN - 1995-4484
DOI - 10.14412/1995-4484-2011-515
Subject(s) - pulmonary hypertension , endothelin receptor , medicine , connective tissue , endothelin 1 , systemic circulation , pathology , cardiology , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here